Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Research Report 2026(Status and Outlook)
Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine is a vaccine for the prevention and treatment of porcine infectious diarrhea and gastroenteritis.
The global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine market size was estimated at USD 125.6 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.85% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine market.
Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
CAVAC
Green Cross Veterinary Products
Harrisvaccines
Komipharm
Nisseiken
Qilu Animal Health
Zoetis
Wuhan Keqian
China Animal Husbandry Industry
Luoyang Huizhong
Shanghai Hile Bio-Technology
Harbin Weike
Harbin Pharmaceutical Group
Jiangsu Nannong
Market Segmentation (by Type)
Live Vaccine
Inactivated Vaccine
Market Segmentation (by Application)
Piglet
Adult Pig
Geographic Segmentation
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine market size was estimated at USD 125.6 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.85% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine market.
Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
CAVAC
Green Cross Veterinary Products
Harrisvaccines
Komipharm
Nisseiken
Qilu Animal Health
Zoetis
Wuhan Keqian
China Animal Husbandry Industry
Luoyang Huizhong
Shanghai Hile Bio-Technology
Harbin Weike
Harbin Pharmaceutical Group
Jiangsu Nannong
Market Segmentation (by Type)
Live Vaccine
Inactivated Vaccine
Market Segmentation (by Application)
Piglet
Adult Pig
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine
1.2 Key Market Segments
1.2.1 Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Segment by Type
1.2.2 Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PORCINE TRANSMISSIBLE GASTROENTERITIS AND EPIDEMIC DIARRHEA DUAL VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PORCINE TRANSMISSIBLE GASTROENTERITIS AND EPIDEMIC DIARRHEA DUAL VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Life Cycle
3.3 Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Competitive Situation and Trends
3.8.1 Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PORCINE TRANSMISSIBLE GASTROENTERITIS AND EPIDEMIC DIARRHEA DUAL VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PORCINE TRANSMISSIBLE GASTROENTERITIS AND EPIDEMIC DIARRHEA DUAL VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market
5.7 ESG Ratings of Leading Companies
6 PORCINE TRANSMISSIBLE GASTROENTERITIS AND EPIDEMIC DIARRHEA DUAL VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales Market Share by Type (2020-2025)
6.3 Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size by Type (2020-2025)
6.4 Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Price by Type (2020-2025)
7 PORCINE TRANSMISSIBLE GASTROENTERITIS AND EPIDEMIC DIARRHEA DUAL VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Sales by Application (2020-2025)
7.3 Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales Growth Rate by Application (2020-2025)
8 PORCINE TRANSMISSIBLE GASTROENTERITIS AND EPIDEMIC DIARRHEA DUAL VACCINE MARKET SALES BY REGION
8.1 Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales by Region
8.1.1 Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales by Region
8.1.2 Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales Market Share by Region
8.2 Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size by Region
8.2.1 Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size by Region
8.2.2 Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size by Region
8.3 North America
8.3.1 North America Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales by Country
8.3.2 North America Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales by Country
8.4.2 Europe Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales by Region
8.5.2 Asia Pacific Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales by Country
8.6.2 South America Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales by Region
8.7.2 Middle East and Africa Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 PORCINE TRANSMISSIBLE GASTROENTERITIS AND EPIDEMIC DIARRHEA DUAL VACCINE MARKET PRODUCTION BY REGION
9.1 Global Production of Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine by Region(2020-2025)
9.2 Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Production
9.4.1 North America Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Production Growth Rate (2020-2025)
9.4.2 North America Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Production
9.5.1 Europe Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Production Growth Rate (2020-2025)
9.5.2 Europe Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Production (2020-2025)
9.6.1 Japan Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Production Growth Rate (2020-2025)
9.6.2 Japan Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Production (2020-2025)
9.7.1 China Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Production Growth Rate (2020-2025)
9.7.2 China Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 CAVAC
10.1.1 CAVAC Basic Information
10.1.2 CAVAC Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Overview
10.1.3 CAVAC Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Market Performance
10.1.4 CAVAC Business Overview
10.1.5 CAVAC SWOT Analysis
10.1.6 CAVAC Recent Developments
10.2 Green Cross Veterinary Products
10.2.1 Green Cross Veterinary Products Basic Information
10.2.2 Green Cross Veterinary Products Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Overview
10.2.3 Green Cross Veterinary Products Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Market Performance
10.2.4 Green Cross Veterinary Products Business Overview
10.2.5 Green Cross Veterinary Products SWOT Analysis
10.2.6 Green Cross Veterinary Products Recent Developments
10.3 Harrisvaccines
10.3.1 Harrisvaccines Basic Information
10.3.2 Harrisvaccines Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Overview
10.3.3 Harrisvaccines Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Market Performance
10.3.4 Harrisvaccines Business Overview
10.3.5 Harrisvaccines SWOT Analysis
10.3.6 Harrisvaccines Recent Developments
10.4 Komipharm
10.4.1 Komipharm Basic Information
10.4.2 Komipharm Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Overview
10.4.3 Komipharm Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Market Performance
10.4.4 Komipharm Business Overview
10.4.5 Komipharm Recent Developments
10.5 Nisseiken
10.5.1 Nisseiken Basic Information
10.5.2 Nisseiken Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Overview
10.5.3 Nisseiken Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Market Performance
10.5.4 Nisseiken Business Overview
10.5.5 Nisseiken Recent Developments
10.6 Qilu Animal Health
10.6.1 Qilu Animal Health Basic Information
10.6.2 Qilu Animal Health Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Overview
10.6.3 Qilu Animal Health Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Market Performance
10.6.4 Qilu Animal Health Business Overview
10.6.5 Qilu Animal Health Recent Developments
10.7 Zoetis
10.7.1 Zoetis Basic Information
10.7.2 Zoetis Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Overview
10.7.3 Zoetis Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Market Performance
10.7.4 Zoetis Business Overview
10.7.5 Zoetis Recent Developments
10.8 Wuhan Keqian
10.8.1 Wuhan Keqian Basic Information
10.8.2 Wuhan Keqian Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Overview
10.8.3 Wuhan Keqian Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Market Performance
10.8.4 Wuhan Keqian Business Overview
10.8.5 Wuhan Keqian Recent Developments
10.9 China Animal Husbandry Industry
10.9.1 China Animal Husbandry Industry Basic Information
10.9.2 China Animal Husbandry Industry Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Overview
10.9.3 China Animal Husbandry Industry Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Market Performance
10.9.4 China Animal Husbandry Industry Business Overview
10.9.5 China Animal Husbandry Industry Recent Developments
10.10 Luoyang Huizhong
10.10.1 Luoyang Huizhong Basic Information
10.10.2 Luoyang Huizhong Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Overview
10.10.3 Luoyang Huizhong Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Market Performance
10.10.4 Luoyang Huizhong Business Overview
10.10.5 Luoyang Huizhong Recent Developments
10.11 Shanghai Hile Bio-Technology
10.11.1 Shanghai Hile Bio-Technology Basic Information
10.11.2 Shanghai Hile Bio-Technology Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Overview
10.11.3 Shanghai Hile Bio-Technology Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Market Performance
10.11.4 Shanghai Hile Bio-Technology Business Overview
10.11.5 Shanghai Hile Bio-Technology Recent Developments
10.12 Harbin Weike
10.12.1 Harbin Weike Basic Information
10.12.2 Harbin Weike Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Overview
10.12.3 Harbin Weike Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Market Performance
10.12.4 Harbin Weike Business Overview
10.12.5 Harbin Weike Recent Developments
10.13 Harbin Pharmaceutical Group
10.13.1 Harbin Pharmaceutical Group Basic Information
10.13.2 Harbin Pharmaceutical Group Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Overview
10.13.3 Harbin Pharmaceutical Group Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Market Performance
10.13.4 Harbin Pharmaceutical Group Business Overview
10.13.5 Harbin Pharmaceutical Group Recent Developments
10.14 Jiangsu Nannong
10.14.1 Jiangsu Nannong Basic Information
10.14.2 Jiangsu Nannong Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Overview
10.14.3 Jiangsu Nannong Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Market Performance
10.14.4 Jiangsu Nannong Business Overview
10.14.5 Jiangsu Nannong Recent Developments
11 PORCINE TRANSMISSIBLE GASTROENTERITIS AND EPIDEMIC DIARRHEA DUAL VACCINE MARKET FORECAST BY REGION
11.1 Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size Forecast
11.2 Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size Forecast by Region
11.2.4 South America Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine by Type (2026-2035)
12.1.2 Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine by Type (2026-2035)
12.2 Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Forecast by Application (2026-2035)
12.2.1 Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales (K Units) Forecast by Application
12.2.2 Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine
1.2 Key Market Segments
1.2.1 Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Segment by Type
1.2.2 Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PORCINE TRANSMISSIBLE GASTROENTERITIS AND EPIDEMIC DIARRHEA DUAL VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PORCINE TRANSMISSIBLE GASTROENTERITIS AND EPIDEMIC DIARRHEA DUAL VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Life Cycle
3.3 Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Competitive Situation and Trends
3.8.1 Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PORCINE TRANSMISSIBLE GASTROENTERITIS AND EPIDEMIC DIARRHEA DUAL VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PORCINE TRANSMISSIBLE GASTROENTERITIS AND EPIDEMIC DIARRHEA DUAL VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market
5.7 ESG Ratings of Leading Companies
6 PORCINE TRANSMISSIBLE GASTROENTERITIS AND EPIDEMIC DIARRHEA DUAL VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales Market Share by Type (2020-2025)
6.3 Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size by Type (2020-2025)
6.4 Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Price by Type (2020-2025)
7 PORCINE TRANSMISSIBLE GASTROENTERITIS AND EPIDEMIC DIARRHEA DUAL VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Sales by Application (2020-2025)
7.3 Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales Growth Rate by Application (2020-2025)
8 PORCINE TRANSMISSIBLE GASTROENTERITIS AND EPIDEMIC DIARRHEA DUAL VACCINE MARKET SALES BY REGION
8.1 Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales by Region
8.1.1 Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales by Region
8.1.2 Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales Market Share by Region
8.2 Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size by Region
8.2.1 Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size by Region
8.2.2 Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size by Region
8.3 North America
8.3.1 North America Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales by Country
8.3.2 North America Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales by Country
8.4.2 Europe Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales by Region
8.5.2 Asia Pacific Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales by Country
8.6.2 South America Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales by Region
8.7.2 Middle East and Africa Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 PORCINE TRANSMISSIBLE GASTROENTERITIS AND EPIDEMIC DIARRHEA DUAL VACCINE MARKET PRODUCTION BY REGION
9.1 Global Production of Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine by Region(2020-2025)
9.2 Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Production
9.4.1 North America Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Production Growth Rate (2020-2025)
9.4.2 North America Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Production
9.5.1 Europe Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Production Growth Rate (2020-2025)
9.5.2 Europe Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Production (2020-2025)
9.6.1 Japan Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Production Growth Rate (2020-2025)
9.6.2 Japan Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Production (2020-2025)
9.7.1 China Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Production Growth Rate (2020-2025)
9.7.2 China Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 CAVAC
10.1.1 CAVAC Basic Information
10.1.2 CAVAC Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Overview
10.1.3 CAVAC Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Market Performance
10.1.4 CAVAC Business Overview
10.1.5 CAVAC SWOT Analysis
10.1.6 CAVAC Recent Developments
10.2 Green Cross Veterinary Products
10.2.1 Green Cross Veterinary Products Basic Information
10.2.2 Green Cross Veterinary Products Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Overview
10.2.3 Green Cross Veterinary Products Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Market Performance
10.2.4 Green Cross Veterinary Products Business Overview
10.2.5 Green Cross Veterinary Products SWOT Analysis
10.2.6 Green Cross Veterinary Products Recent Developments
10.3 Harrisvaccines
10.3.1 Harrisvaccines Basic Information
10.3.2 Harrisvaccines Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Overview
10.3.3 Harrisvaccines Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Market Performance
10.3.4 Harrisvaccines Business Overview
10.3.5 Harrisvaccines SWOT Analysis
10.3.6 Harrisvaccines Recent Developments
10.4 Komipharm
10.4.1 Komipharm Basic Information
10.4.2 Komipharm Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Overview
10.4.3 Komipharm Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Market Performance
10.4.4 Komipharm Business Overview
10.4.5 Komipharm Recent Developments
10.5 Nisseiken
10.5.1 Nisseiken Basic Information
10.5.2 Nisseiken Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Overview
10.5.3 Nisseiken Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Market Performance
10.5.4 Nisseiken Business Overview
10.5.5 Nisseiken Recent Developments
10.6 Qilu Animal Health
10.6.1 Qilu Animal Health Basic Information
10.6.2 Qilu Animal Health Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Overview
10.6.3 Qilu Animal Health Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Market Performance
10.6.4 Qilu Animal Health Business Overview
10.6.5 Qilu Animal Health Recent Developments
10.7 Zoetis
10.7.1 Zoetis Basic Information
10.7.2 Zoetis Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Overview
10.7.3 Zoetis Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Market Performance
10.7.4 Zoetis Business Overview
10.7.5 Zoetis Recent Developments
10.8 Wuhan Keqian
10.8.1 Wuhan Keqian Basic Information
10.8.2 Wuhan Keqian Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Overview
10.8.3 Wuhan Keqian Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Market Performance
10.8.4 Wuhan Keqian Business Overview
10.8.5 Wuhan Keqian Recent Developments
10.9 China Animal Husbandry Industry
10.9.1 China Animal Husbandry Industry Basic Information
10.9.2 China Animal Husbandry Industry Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Overview
10.9.3 China Animal Husbandry Industry Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Market Performance
10.9.4 China Animal Husbandry Industry Business Overview
10.9.5 China Animal Husbandry Industry Recent Developments
10.10 Luoyang Huizhong
10.10.1 Luoyang Huizhong Basic Information
10.10.2 Luoyang Huizhong Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Overview
10.10.3 Luoyang Huizhong Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Market Performance
10.10.4 Luoyang Huizhong Business Overview
10.10.5 Luoyang Huizhong Recent Developments
10.11 Shanghai Hile Bio-Technology
10.11.1 Shanghai Hile Bio-Technology Basic Information
10.11.2 Shanghai Hile Bio-Technology Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Overview
10.11.3 Shanghai Hile Bio-Technology Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Market Performance
10.11.4 Shanghai Hile Bio-Technology Business Overview
10.11.5 Shanghai Hile Bio-Technology Recent Developments
10.12 Harbin Weike
10.12.1 Harbin Weike Basic Information
10.12.2 Harbin Weike Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Overview
10.12.3 Harbin Weike Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Market Performance
10.12.4 Harbin Weike Business Overview
10.12.5 Harbin Weike Recent Developments
10.13 Harbin Pharmaceutical Group
10.13.1 Harbin Pharmaceutical Group Basic Information
10.13.2 Harbin Pharmaceutical Group Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Overview
10.13.3 Harbin Pharmaceutical Group Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Market Performance
10.13.4 Harbin Pharmaceutical Group Business Overview
10.13.5 Harbin Pharmaceutical Group Recent Developments
10.14 Jiangsu Nannong
10.14.1 Jiangsu Nannong Basic Information
10.14.2 Jiangsu Nannong Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Overview
10.14.3 Jiangsu Nannong Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Market Performance
10.14.4 Jiangsu Nannong Business Overview
10.14.5 Jiangsu Nannong Recent Developments
11 PORCINE TRANSMISSIBLE GASTROENTERITIS AND EPIDEMIC DIARRHEA DUAL VACCINE MARKET FORECAST BY REGION
11.1 Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size Forecast
11.2 Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size Forecast by Region
11.2.4 South America Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine by Type (2026-2035)
12.1.2 Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine by Type (2026-2035)
12.2 Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Forecast by Application (2026-2035)
12.2.1 Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales (K Units) Forecast by Application
12.2.2 Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size by Type (M USD)
Table 4. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size by Application
Table 5. Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size Comparison by Region (M USD)
Table 6. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine as of 2025)
Table 11. Global Market Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales by Type (K Units)
Table 27. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size by Type (M USD)
Table 28. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales (K Units) by Type (2020-2025)
Table 29. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales Market Share by Type (2020-2025)
Table 30. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size (M USD) by Type (2020-2025)
Table 31. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Share by Type (2020-2025)
Table 32. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Price (USD/Unit) by Type (2020-2025)
Table 33. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales (K Units) by Application
Table 34. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size by Application
Table 35. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales by Application (2020-2025) & (K Units)
Table 36. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales Market Share by Application (2020-2025)
Table 37. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size by Application (2020-2025) & (M USD)
Table 38. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Share by Application (2020-2025)
Table 39. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales Growth Rate by Application (2020-2025)
Table 40. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales by Region (2020-2025) & (K Units)
Table 41. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales Market Share by Region (2020-2025)
Table 42. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size by Region (2020-2025) & (M USD)
Table 43. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size by Region (2020-2025)
Table 44. North America Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales by Country (2020-2025) & (K Units)
Table 45. North America Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales by Country (2020-2025) & (K Units)
Table 47. Europe Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size by Region (2020-2025) & (M USD)
Table 50. South America Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales by Country (2020-2025) & (K Units)
Table 51. South America Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size by Region (2020-2025) & (M USD)
Table 54. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Production (K Units) by Region(2020-2025)
Table 55. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Revenue Market Share by Region (2020-2025)
Table 57. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. CAVAC Basic Information
Table 63. CAVAC Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Overview
Table 64. CAVAC Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. CAVAC Business Overview
Table 66. CAVAC SWOT Analysis
Table 67. CAVAC Recent Developments
Table 68. Green Cross Veterinary Products Basic Information
Table 69. Green Cross Veterinary Products Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Overview
Table 70. Green Cross Veterinary Products Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Green Cross Veterinary Products Business Overview
Table 72. Green Cross Veterinary Products SWOT Analysis
Table 73. Green Cross Veterinary Products Recent Developments
Table 74. Harrisvaccines Basic Information
Table 75. Harrisvaccines Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Overview
Table 76. Harrisvaccines Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Harrisvaccines Business Overview
Table 78. Harrisvaccines SWOT Analysis
Table 79. Harrisvaccines Recent Developments
Table 80. Komipharm Basic Information
Table 81. Komipharm Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Overview
Table 82. Komipharm Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Komipharm Business Overview
Table 84. Komipharm Recent Developments
Table 85. Nisseiken Basic Information
Table 86. Nisseiken Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Overview
Table 87. Nisseiken Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Nisseiken Business Overview
Table 89. Nisseiken Recent Developments
Table 90. Qilu Animal Health Basic Information
Table 91. Qilu Animal Health Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Overview
Table 92. Qilu Animal Health Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Qilu Animal Health Business Overview
Table 94. Qilu Animal Health Recent Developments
Table 95. Zoetis Basic Information
Table 96. Zoetis Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Overview
Table 97. Zoetis Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Zoetis Business Overview
Table 99. Zoetis Recent Developments
Table 100. Wuhan Keqian Basic Information
Table 101. Wuhan Keqian Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Overview
Table 102. Wuhan Keqian Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Wuhan Keqian Business Overview
Table 104. Wuhan Keqian Recent Developments
Table 105. China Animal Husbandry Industry Basic Information
Table 106. China Animal Husbandry Industry Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Overview
Table 107. China Animal Husbandry Industry Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. China Animal Husbandry Industry Business Overview
Table 109. China Animal Husbandry Industry Recent Developments
Table 110. Luoyang Huizhong Basic Information
Table 111. Luoyang Huizhong Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Overview
Table 112. Luoyang Huizhong Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Luoyang Huizhong Business Overview
Table 114. Luoyang Huizhong Recent Developments
Table 115. Shanghai Hile Bio-Technology Basic Information
Table 116. Shanghai Hile Bio-Technology Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Overview
Table 117. Shanghai Hile Bio-Technology Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Shanghai Hile Bio-Technology Business Overview
Table 119. Shanghai Hile Bio-Technology Recent Developments
Table 120. Harbin Weike Basic Information
Table 121. Harbin Weike Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Overview
Table 122. Harbin Weike Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Harbin Weike Business Overview
Table 124. Harbin Weike Recent Developments
Table 125. Harbin Pharmaceutical Group Basic Information
Table 126. Harbin Pharmaceutical Group Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Overview
Table 127. Harbin Pharmaceutical Group Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Harbin Pharmaceutical Group Business Overview
Table 129. Harbin Pharmaceutical Group Recent Developments
Table 130. Jiangsu Nannong Basic Information
Table 131. Jiangsu Nannong Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Overview
Table 132. Jiangsu Nannong Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Jiangsu Nannong Business Overview
Table 134. Jiangsu Nannong Recent Developments
Table 135. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales Forecast by Region (2026-2035) & (K Units)
Table 136. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 137. North America Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales Forecast by Country (2026-2035) & (K Units)
Table 138. North America Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 139. Europe Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales Forecast by Country (2026-2035) & (K Units)
Table 140. Europe Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 141. Asia Pacific Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales Forecast by Region (2026-2035) & (K Units)
Table 142. Asia Pacific Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 143. South America Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales Forecast by Country (2026-2035) & (K Units)
Table 144. South America Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 145. Middle East and Africa Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales Forecast by Country (2026-2035) & (Units)
Table 146. Middle East and Africa Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 147. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales Forecast by Type (2026-2035) & (K Units)
Table 148. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size Forecast by Type (2026-2035) & (M USD)
Table 149. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Price Forecast by Type (2026-2035) & (USD/Unit)
Table 150. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales (K Units) Forecast by Application (2026-2035)
Table 151. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size by Type (M USD)
Table 4. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size by Application
Table 5. Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size Comparison by Region (M USD)
Table 6. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine as of 2025)
Table 11. Global Market Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales by Type (K Units)
Table 27. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size by Type (M USD)
Table 28. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales (K Units) by Type (2020-2025)
Table 29. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales Market Share by Type (2020-2025)
Table 30. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size (M USD) by Type (2020-2025)
Table 31. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Share by Type (2020-2025)
Table 32. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Price (USD/Unit) by Type (2020-2025)
Table 33. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales (K Units) by Application
Table 34. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size by Application
Table 35. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales by Application (2020-2025) & (K Units)
Table 36. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales Market Share by Application (2020-2025)
Table 37. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size by Application (2020-2025) & (M USD)
Table 38. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Share by Application (2020-2025)
Table 39. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales Growth Rate by Application (2020-2025)
Table 40. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales by Region (2020-2025) & (K Units)
Table 41. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales Market Share by Region (2020-2025)
Table 42. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size by Region (2020-2025) & (M USD)
Table 43. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size by Region (2020-2025)
Table 44. North America Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales by Country (2020-2025) & (K Units)
Table 45. North America Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales by Country (2020-2025) & (K Units)
Table 47. Europe Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size by Region (2020-2025) & (M USD)
Table 50. South America Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales by Country (2020-2025) & (K Units)
Table 51. South America Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size by Region (2020-2025) & (M USD)
Table 54. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Production (K Units) by Region(2020-2025)
Table 55. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Revenue Market Share by Region (2020-2025)
Table 57. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. CAVAC Basic Information
Table 63. CAVAC Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Overview
Table 64. CAVAC Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. CAVAC Business Overview
Table 66. CAVAC SWOT Analysis
Table 67. CAVAC Recent Developments
Table 68. Green Cross Veterinary Products Basic Information
Table 69. Green Cross Veterinary Products Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Overview
Table 70. Green Cross Veterinary Products Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Green Cross Veterinary Products Business Overview
Table 72. Green Cross Veterinary Products SWOT Analysis
Table 73. Green Cross Veterinary Products Recent Developments
Table 74. Harrisvaccines Basic Information
Table 75. Harrisvaccines Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Overview
Table 76. Harrisvaccines Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Harrisvaccines Business Overview
Table 78. Harrisvaccines SWOT Analysis
Table 79. Harrisvaccines Recent Developments
Table 80. Komipharm Basic Information
Table 81. Komipharm Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Overview
Table 82. Komipharm Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Komipharm Business Overview
Table 84. Komipharm Recent Developments
Table 85. Nisseiken Basic Information
Table 86. Nisseiken Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Overview
Table 87. Nisseiken Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Nisseiken Business Overview
Table 89. Nisseiken Recent Developments
Table 90. Qilu Animal Health Basic Information
Table 91. Qilu Animal Health Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Overview
Table 92. Qilu Animal Health Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Qilu Animal Health Business Overview
Table 94. Qilu Animal Health Recent Developments
Table 95. Zoetis Basic Information
Table 96. Zoetis Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Overview
Table 97. Zoetis Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Zoetis Business Overview
Table 99. Zoetis Recent Developments
Table 100. Wuhan Keqian Basic Information
Table 101. Wuhan Keqian Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Overview
Table 102. Wuhan Keqian Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Wuhan Keqian Business Overview
Table 104. Wuhan Keqian Recent Developments
Table 105. China Animal Husbandry Industry Basic Information
Table 106. China Animal Husbandry Industry Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Overview
Table 107. China Animal Husbandry Industry Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. China Animal Husbandry Industry Business Overview
Table 109. China Animal Husbandry Industry Recent Developments
Table 110. Luoyang Huizhong Basic Information
Table 111. Luoyang Huizhong Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Overview
Table 112. Luoyang Huizhong Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Luoyang Huizhong Business Overview
Table 114. Luoyang Huizhong Recent Developments
Table 115. Shanghai Hile Bio-Technology Basic Information
Table 116. Shanghai Hile Bio-Technology Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Overview
Table 117. Shanghai Hile Bio-Technology Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Shanghai Hile Bio-Technology Business Overview
Table 119. Shanghai Hile Bio-Technology Recent Developments
Table 120. Harbin Weike Basic Information
Table 121. Harbin Weike Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Overview
Table 122. Harbin Weike Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Harbin Weike Business Overview
Table 124. Harbin Weike Recent Developments
Table 125. Harbin Pharmaceutical Group Basic Information
Table 126. Harbin Pharmaceutical Group Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Overview
Table 127. Harbin Pharmaceutical Group Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Harbin Pharmaceutical Group Business Overview
Table 129. Harbin Pharmaceutical Group Recent Developments
Table 130. Jiangsu Nannong Basic Information
Table 131. Jiangsu Nannong Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Overview
Table 132. Jiangsu Nannong Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Jiangsu Nannong Business Overview
Table 134. Jiangsu Nannong Recent Developments
Table 135. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales Forecast by Region (2026-2035) & (K Units)
Table 136. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 137. North America Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales Forecast by Country (2026-2035) & (K Units)
Table 138. North America Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 139. Europe Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales Forecast by Country (2026-2035) & (K Units)
Table 140. Europe Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 141. Asia Pacific Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales Forecast by Region (2026-2035) & (K Units)
Table 142. Asia Pacific Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 143. South America Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales Forecast by Country (2026-2035) & (K Units)
Table 144. South America Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 145. Middle East and Africa Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales Forecast by Country (2026-2035) & (Units)
Table 146. Middle East and Africa Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 147. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales Forecast by Type (2026-2035) & (K Units)
Table 148. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size Forecast by Type (2026-2035) & (M USD)
Table 149. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Price Forecast by Type (2026-2035) & (USD/Unit)
Table 150. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales (K Units) Forecast by Application (2026-2035)
Table 151. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size (M USD), 2025-2035
Figure 5. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size (M USD) (2020-2035)
Figure 6. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Life Cycle
Figure 13. Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales Share by Manufacturers in 2025
Figure 14. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Revenue Share by Manufacturers in 2025
Figure 15. Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Revenue in 2025
Figure 18. Industry Chain Map of Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine
Figure 19. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market PEST Analysis
Figure 20. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Share by Type
Figure 27. Sales Market Share of Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine by Type in 2025
Figure 29. Market Share of Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine by Type (2020-2025)
Figure 30. Market Share of Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Share by Application
Figure 33. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales Market Share by Application in 2025
Figure 35. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Share by Application (2020-2025)
Figure 36. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Share by Application in 2025
Figure 37. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size by Region (2020-2025)
Figure 40. North America Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales Market Share by Country in 2024
Figure 43. North America Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size by Country in 2024
Figure 45. U.S. Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales Market Share by Country in 2024
Figure 53. Europe Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size by Country in 2024
Figure 55. Germany Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size by Region in 2024
Figure 68. China Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales and Growth Rate (K Units)
Figure 79. South America Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales Market Share by Country in 2024
Figure 80. South America Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size by Country in 2024
Figure 82. Brazil Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size by Region in 2024
Figure 92. Saudi Arabia Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Production (K Units) Growth Rate (2020-2025)
Figure 106. China Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Share Forecast by Type (2026-2035)
Figure 111. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales Forecast by Application (2026-2035)
Figure 112. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size (M USD), 2025-2035
Figure 5. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size (M USD) (2020-2035)
Figure 6. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Product Life Cycle
Figure 13. Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales Share by Manufacturers in 2025
Figure 14. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Revenue Share by Manufacturers in 2025
Figure 15. Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Revenue in 2025
Figure 18. Industry Chain Map of Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine
Figure 19. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market PEST Analysis
Figure 20. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Share by Type
Figure 27. Sales Market Share of Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine by Type in 2025
Figure 29. Market Share of Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine by Type (2020-2025)
Figure 30. Market Share of Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Share by Application
Figure 33. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales Market Share by Application in 2025
Figure 35. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Share by Application (2020-2025)
Figure 36. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Share by Application in 2025
Figure 37. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size by Region (2020-2025)
Figure 40. North America Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales Market Share by Country in 2024
Figure 43. North America Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size by Country in 2024
Figure 45. U.S. Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales Market Share by Country in 2024
Figure 53. Europe Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size by Country in 2024
Figure 55. Germany Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size by Region in 2024
Figure 68. China Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales and Growth Rate (K Units)
Figure 79. South America Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales Market Share by Country in 2024
Figure 80. South America Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size by Country in 2024
Figure 82. Brazil Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size by Region in 2024
Figure 92. Saudi Arabia Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Production (K Units) Growth Rate (2020-2025)
Figure 106. China Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Share Forecast by Type (2026-2035)
Figure 111. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Sales Forecast by Application (2026-2035)
Figure 112. Global Porcine Transmissible Gastroenteritis And Epidemic Diarrhea Dual Vaccine Market Share Forecast by Application (2026-2035)
